{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T02:37:18Z","timestamp":1791686238165,"version":"4.3.4"},"reference-count":38,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T00:00:00Z","timestamp":1675123200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010665","name":"H2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","award":["813409"],"award-info":[{"award-number":["813409"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.jtha.2023.01.025","type":"journal-article","created":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T12:43:45Z","timestamp":1675255425000},"page":"1238-1247","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Exploring phenotypes of deep vein thrombosis in relation to clinical outcomes beyond recurrence"],"prefix":"10.1016","volume":"21","author":[{"given":"Aaron F.J.","family":"Iding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Pallares Robles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"ten Cate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"ten Cate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp S.","family":"Wild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arina J.","family":"ten Cate-Hoek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2023.01.025_bib1","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0140-6736(20)32658-1","article-title":"Venous thromboembolism","volume":"398","author":"Khan","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jtha.2023.01.025_bib2","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1111\/jth.13336","article-title":"Subcommittees on Control of Anticoagulation, and Predictive and Diagnostic Variables in Thrombotic Disease. Categorization of patients as having provoked or unprovoked venous thromboembolism: guidance from the SSC of ISTH","volume":"14","author":"Kearon","year":"2016","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.01.025_bib3","doi-asserted-by":"crossref","first-page":"410","DOI":"10.7326\/M17-0868","article-title":"Screening for occult cancer in patients with unprovoked venous thromboembolism: a systematic review and meta-analysis of individual patient data","volume":"167","author":"van Es","year":"2017","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jtha.2023.01.025_bib4","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/rth2.12085","article-title":"Prevention and treatment of the post-thrombotic syndrome","volume":"2","author":"Ten Cate-Hoek","year":"2018","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.01.025_bib5","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.thromres.2021.05.009","article-title":"Frequency and incidence of arterial events in patients with venous thromboembolism compared to the general population: a systematic review and meta-analysis of cohort studies","volume":"203","author":"Noumegni","year":"2021","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2023.01.025_bib6","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1016\/j.chest.2021.07.056","article-title":"Executive summary: antithrombotic therapy for VTE disease: second update of the CHEST guideline and expert panel report","volume":"160","author":"Stevens","year":"2021","journal-title":"Chest"},{"key":"10.1016\/j.jtha.2023.01.025_bib7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejvs.2020.09.023","article-title":"Editor\u2019s choice \u2013 European Society for Vascular Surgery (ESVS) 2021 Clinical Practice Guidelines on the Management of Venous Thrombosis","volume":"61","author":"Kakkos","year":"2021","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jtha.2023.01.025_bib8","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1182\/bloodadvances.2020001830","article-title":"American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism","volume":"4","author":"Ortel","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2023.01.025_bib9","doi-asserted-by":"crossref","first-page":"m1565","DOI":"10.1136\/bmj.m1565","article-title":"Venous thromboembolism in adults: summary of updated NICE guidance on diagnosis, management, and thrombophilia testing","volume":"369","author":"McCormack","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.jtha.2023.01.025_bib10","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1111\/jth.14156","article-title":"Reduced-dose direct oral anticoagulants in the extended treatment of venous thromboembolism: a systematic review and meta-analysis","volume":"16","author":"Vasanthamohan","year":"2018","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.01.025_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12502","article-title":"Considerations for use of direct oral anticoagulants in arterial disease","volume":"5","author":"Siegal","year":"2021","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.01.025_bib12","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ijcard.2018.03.098","article-title":"Identifying novel phenotypes of acute heart failure using cluster analysis of clinical variables","volume":"262","author":"Horiuchi","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jtha.2023.01.025_bib13","doi-asserted-by":"crossref","first-page":"843","DOI":"10.3390\/biomedicines9070843","article-title":"Clinical phenotype classification of atrial fibrillation patients using cluster analysis and associations with trial-adjudicated outcomes","volume":"9","author":"Vitolo","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.jtha.2023.01.025_bib14","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.2147\/COPD.S268332","article-title":"Different clusters in patients with chronic obstructive pulmonary disease (Copd): a two-center study in brazil","volume":"15","author":"Zucchi","year":"2020","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.jtha.2023.01.025_bib15","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3389\/fncom.2019.00031","article-title":"The application of unsupervised clustering methods to Alzheimer\u2019s disease","volume":"13","author":"Alashwal","year":"2019","journal-title":"Front Comput Neurosci"},{"key":"10.1016\/j.jtha.2023.01.025_bib16","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/rth2.12079","article-title":"Risk factors for recurrence in deep vein thrombosis patients following a tailored anticoagulant treatment incorporating residual vein obstruction","volume":"2","author":"Nagler","year":"2018","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.01.025_bib17","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01647-2019","volume":"54","author":"Konstantinides","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jtha.2023.01.025_bib18","first-page":"8","article-title":"Validation of the Villalta scale in assessing post-thrombotic syndrome using clinical, duplex, and hemodynamic comparators","volume":"2","author":"Lattimer","year":"2014","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jtha.2023.01.025_bib19","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1161\/CIRCULATIONAHA.117.033502","article-title":"2017 cardiovascular and stroke endpoint definitions for clinical trials","volume":"137","author":"Hicks","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2023.01.025_bib20","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/bioinformatics\/btr597","article-title":"Missforest-non-parametric missing value imputation for mixed-type data","volume":"28","author":"Stekhoven","year":"2012","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jtha.2023.01.025_bib21","first-page":"1","article-title":"Nbclust: an R package for determining the relevant number of clusters in a data set","volume":"61","author":"Charrad","year":"2014","journal-title":"J\u00a0Stat Softw"},{"key":"10.1016\/j.jtha.2023.01.025_bib23","first-page":"CD010813","article-title":"Combined oral contraceptives: venous thrombosis","volume":"3","author":"de Bastos","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jtha.2023.01.025_bib24","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/S0049-3848(13)70009-4","article-title":"Mechanisms of hormonal therapy related thrombosis","volume":"131","author":"Sandset","year":"2013","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2023.01.025_bib25","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.thromres.2021.03.012","article-title":"Oral contraceptives and hormone replacement therapy: How strong a risk factor for venous thromboembolism?","volume":"202","author":"Skeith","year":"2021","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2023.01.025_bib26","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/ajh.21059","article-title":"Smoking increases the risk of venous thrombosis and acts synergistically with oral contraceptive use","volume":"83","author":"Pomp","year":"2008","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtha.2023.01.025_bib27","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1111\/jth.15661","article-title":"Risk of recurrence in women with venous thromboembolism related to estrogen-containing contraceptives: systematic review and meta-analysis","volume":"20","author":"Wiegers","year":"2022","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.01.025_bib28","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/eurheartj\/ehz405","article-title":"ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): supplementary data","volume":"41","author":"Konstantinides","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtha.2023.01.025_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/eurheartj\/ehab816","volume":"43","author":"Klok","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtha.2023.01.025_bib30","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1161\/CIRCULATIONAHA.117.031062","article-title":"Frequency, predictors, and impact of combined antiplatelet therapy on venous thromboembolism in patients with symptomatic atherosclerosis","volume":"137","author":"Cavallari","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2023.01.025_bib31","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1161\/CIRCULATIONAHA.107.709204","article-title":"Cardiovascular risk factors and venous thromboembolism: a meta-analysis","volume":"117","author":"Ageno","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2023.01.025_bib32","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ijcard.2017.11.055","article-title":"Increased risk and severity of unprovoked venous thromboembolism with clustering cardiovascular risk factors for atherosclerosis: results of the REMOTEV registry","volume":"252","author":"Gaertner","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jtha.2023.01.025_bib33","first-page":"CD011088","article-title":"Secondary prevention of recurrent venous thromboembolism after initial oral anticoagulation therapy in patients with unprovoked venous thromboembolism","volume":"12","author":"Robertson","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jtha.2023.01.025_bib34","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1056\/NEJMoa1709118","article-title":"Rivaroxaban with or without aspirin in stable cardiovascular disease","volume":"377","author":"Eikelboom","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2023.01.025_bib35","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.thromres.2022.11.023","article-title":"Translational insights into mechanisms underlying residual venous obstruction and the role of factor XI, P-selectin and GPVI in recurrent venous thromboembolism","volume":"221","author":"Iding","year":"2023","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2023.01.025_bib36","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.thromres.2022.08.011","article-title":"RIETE Investigators. The hazard of combining anticoagulants with antiplatelets in patients with venous thromboembolism: findings from the RIETE registry","volume":"218","author":"Prandoni","year":"2022","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2023.01.025_bib37","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/j.1538-7836.2006.01795.x","article-title":"Post-thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months","volume":"4","author":"Schulman","year":"2006","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.01.025_bib38","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1111\/bjh.16275","volume":"188","author":"Bradbury","year":"2020","journal-title":"Brit J Haematol"},{"key":"10.1016\/j.jtha.2023.01.025_bib39","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.03002-2021","article-title":"Risk stratification for predicting recurrent venous thromboembolism after discontinuation of anticoagulation: a post hoc analysis of a French prospective multicentre study","volume":"60","author":"Le Mao","year":"2022","journal-title":"Eur Respir J"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783623000740?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783623000740?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:38:40Z","timestamp":1761536320000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783623000740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S1538783623000740"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2023.01.025","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring phenotypes of deep vein thrombosis in relation to clinical outcomes beyond recurrence","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2023.01.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}]}}